Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

New York Marijuana Companies Apply for a License Before Friday’s Deadline

Jun 10, 2015 • 3:05 PM EDT
1 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Yesterday, the New York State Department of Health announced that 43 companies applied for five licenses to grow and sell medical marijuana. The applicants had to complete a massive amount of paperwork and pay $10,000 just for the opportunity to apply.

The companies that are selected will not have it easy. First, they have to pay the state $200,000. Second, they will be operating under a highly regulated and restricted program. If the state suspects any foul play, they can shut down the business immediately.

Each company that is selected will be allowed to open one cultivation facility and four dispensaries. On Tuesday, the state released the names of the applicants. Most of these companies had already stated that they were applying for a license, as well as where they plan on opening their dispensaries.

A very restricted program

The Health Department’s regulations have been criticized by a number of marijuana advocates as being too restrictive. New York’s medical marijuana program will allow state-certified doctors to prescribe medical marijuana to patients suffering from cancer, epilepsy and other serious diseases and conditions.

The patients who actually qualify for medical marijuana will face restrictions such as medical marijuana cannot be smoked. Registered patients will be allowed to consume medical marijuana through pills, oils and vaporizers.

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.